Navigation Links
Charles Galea Joins dicentra as Director of Clinical Research – Business Development
Date:7/18/2020

dicentra, a leading Contract Research Organization (CRO) and global consulting firm for the life sciences and food industries, is pleased to announce that Charles Galea has joined its clinical trials division as its new Director of Clinical Research – Business Development.

Charles is an accomplished and results-driven sales executive with over 10 years of expertise in business management, account relations, client acquisition and retention, budgeting, and achieving remarkable business growth.

“Our CRO plays such an integral part in the advancement of the global nutraceutical industry and I look forward to helping our clients reach their goals, help substantiate their claims, and ultimately grow,” states Charles Galea, Director of Clinical Research.

Charles will be leading the relationship, satisfaction, and retention of clients for the clinical trial division, and will be working directly with the senior leadership team to support the continued growth of the CRO division.

“We’ve been fortunate to see our clinical trials division grow at a great rate even during a global pandemic,” states Vice President, Peter Wojewnik. “Charles will be able to aid us in our execution of clinical trials and lead the division’s continued growth and success well into the future.”

About dicentra
dicentra is a full-service Contract Research Organization (CRO) and professional consulting firm that specializes in addressing all matters related to safety, quality and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for nutraceutical and food products to gain market access and build confidence in your brand. We achieve this through our four business divisions: Life Sciences, Food Safety & Quality, Global Certifications, and Clinical Trials. Since our inception in 2002, we have completed over 18,000 projects and serviced over 1,200 companies internationally.

Our beautiful CRO clinic is located in the heart of downtown Toronto, one of the world’s most multicultural cities, boasting over 200 ethnic groups. With over 6.5 million people located right at our doorstep, we are able to recruit study subjects for clinical trials at a very fast rate, allowing our study sponsors to obtain their results sooner. For more information, visit http://www.dicentra.com.

Read the full story at https://www.prweb.com/releases/charles_galea_joins_dicentra_as_director_of_clinical_research_business_development/prweb17247627.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Charles W. Stellar Named WEDI President and CEO
2. Charleston, SC Law Firm, Rosen Hagood, Represents Biotech Workers in Obtaining $53.5 million Verdict Related to Employee Incentive Plan
3. WestEdge Launched as World Class Research Community to Help Advance Economic Future of Charleston, SC
4. PMG Research of Charleston is Participating in a Phase III Trial of an Investigational Vaccine for the Prevention of Clostridium difficile
5. Neurotech Announces Appointment of Dr. Charles Johnson as Chief Medical Officer
6. Baylor Charles A. Sammons Cancer Center at Dallas Teams with OncLive's Strategic Alliance Partnership Program
7. Benchworks Appoints Charles Laudadio, MD, MBA As Medical Director
8. Charles Marcus receives American research prize
9. Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage
10. Charles Hauser, John Vann named to PMG Research Board of Directors
11. Charles M. Lieber receives the first Nano Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said ... on the market and we were pleased that the IFT jury recognized that.” reFRESH™ ... creating a natural way to extend the shelf life and improve the safety of ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider ... for businesses of all types to ensure cleanliness, distancing and occupancy with its patent ... Safe Space™ enabled business will provide a health performance index system that scores all ...
Breaking Biology Technology:
(Date:8/7/2020)... ... August 06, 2020 , ... ... pleased to announce that Eric Chen and Jessica Wong have joined the company’s ... & Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient ... that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of ... 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting ...
Breaking Biology News(10 mins):